FY2014 Financial Highlights
Group revenues increased by 16.9% to US$643.9m
Healthcare division revenue increased by 14.8% to US$332.2m
Distribution division revenue grew by 12.9% to US$338.9m
EBITDA increased by 10.2% to US$102.5m
EBITDA margin declined by 96bps to 15.9%
Net profits increased by 12.1% to US$77.5m
Net profit margins declined by 51bps to 12.0%
Earnings per share (EPS) amounted to US$0.412
Proposed dividend pay-out ratio is maintained at 20% of profit after tax, amounting to GBP 5.4 pence per share
Total capital expenditure for the year reached US$112.3m, 35.8% higher compared to FY20134
Net debt reached US$113.0m as the Group continued to advance its on-going healthcare projects
